News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Kaleo Pharma
NEWS
JOBS
NEWS
Policy
Three Companies Relent to FTC Demands, Delist Patents from FDA’s Orange Book
GSK withdrew three patents related to its asthma inhalers while Impax delisted both of its patents for Adrenaclick and Kaléo delisted eight patents covering Auvi-Q—the companies’ respective epinephrine auto-injectors.
December 22, 2023
·
2 min read
·
Kate Goodwin
BioCapital
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio
February 10, 2017
·
1 min read
IN THE PRESS
BioCapital
Kaléo Confirms U.S. Availability of AUVI-Q® (epinephrine injection, USP) Auto-injector for Back-to-School Season
August 14, 2018
·
7 min read
FDA
With Life-Threatening Allergies Diagnosed in Infancy, kaléo Announces Availability of First and Only FDA-Approved Epinephrine Auto-Injector (EAI) for Infants and Toddlers Weighing 16.5 to 33 Pounds (7.5 to 15 kilograms)
April 26, 2018
·
9 min read
FDA
U.S. FDA Approves Kaleo’s AUVI-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
November 20, 2017
·
9 min read
BioCapital
Kaleo Donates Thousands Of AUVI-Q (Epinephrine Injection, USP) And EVZIO (Naloxone HCl injection) Auto-Injectors To Hurricane Harvey Relief Efforts
September 5, 2017
·
12 min read
Policy
U.S. FDA Grants Priority Review For An Epinephrine Auto-Injector In Development By Kaleo Specifically For Infants And Small Children
July 27, 2017
·
9 min read
BioCapital
Kaleo Donates 250,000th EVZIO (naloxone HCl injection) Auto-Injector To Help Fight Opioid Overdose Epidemic
June 22, 2017
·
10 min read
BioCapital
Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions
January 19, 2017
·
7 min read
BioCapital
Mylan Rival Kaleo Will Re-Launch EpiPen Competitor After Being Yanked From Market Last Year
October 26, 2016
·
8 min read
Drug Development
Kaleo Presents Studies At PAINWeek 2016 Comparing Naloxone Intramuscular Injection And Naloxone Intranasal Administration
September 8, 2016
·
11 min read
BioCapital
Kaleo Release: More Than 1000 Lives Reported Saved With Help Of EVZIO (naloxone HCl injection) Auto-injectors
March 29, 2016
·
9 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details